doi: 10.1016/S0140-6736(70)92693-0 28 SilerURomaoSTejeraEPastukhovOKuzmenkoEValenciaRGet al
Some studies in older adults have shown improvements in memory and cognitive vitality, while others have found no significant effect
The decision to continue or discontinue Mounjaro should be made collaboratively, considering the substantial metabolic benefits against theoretical concerns
The study was done over a 52-week period where participants took different doses of Qsymia
Some patients who used GLP-1 drugs (including Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, Trulicity, Saxenda, and Victoza ) report developing acute pancreatitis during treatment, with some experiencing recurrence, chronic inflammation, or lasting pancreatic impairment